Warfarin Pharmacogenetics Survey from UCSF and Anticoagulation Forum

ClotCare: Blood Clots, Stroke, Heart Attack

Tuesday, December 3, 2024

Home | DVT/PE | Blood Clots | Coumadin/Warfarin | New Patients | Self Testing | Email List | Donate

Pick a Topic: Home New Postings Patient Postings Clinician Postings Join Our Email List Useful Web Links CE Opportunities Training Programs Guidelines DVT & PE Stories Editorial Board Financial Support About ClotCare DVT Coalition Contact Us Find info on a: Specific Medicine or Treatment Type of Medicine or Treatment Condition or Medical Procedure Lab Test Procedure Management Issue ClotCare complies with the HONcode standard for trustworthy health information: verify here. ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.	Warfarin Pharmacogenetics Survey Marie B. Walker December, 2008 In collaboration with the Anticoagulation Forum, the University of California, San Francisco Pharmacy School is conducting a survey, "Anticoagulation Providers and Warfarin Pharmacogenetics." Anticoagulation therapy providers in North America are asked to participate. The topic of this survey concerns the clinical application of warfarin pharmacogenetics. As you may know, the FDA recommends lowering the starting dose of warfarin in patients with certain genetic variants. See http://www.clotcare.com/clotcare/warfaringenetictesting.aspx for more on this issue. The objective of the study is to identify those factors that may influence the clinical application of this new recommendation because it requires the application of new knowledge and technology. This survey study has been approved by Committee on Human Research at the University of California, San Francisco. Questions may be directed to Jaekyu Shin, Pharm.D, BCPS at 415-514-2747 (office, from 8 AM to 5 PM Pacific Standard Time) or email me at shinj@pharmacy.ucsf.edu. Data collected from this study will be used only for research purposes. The survey questionnaire consists of 25 questions. It is estimated to take about 10-15 minutes to participate in the study. The survey questionnaire can be found at http://www.surveymonkey.com/s.aspx?sm=kUNNWxNYuskhaOjhQIxdYQ_3d_3d The conclusions of the survey and the answer keys to the knowledge questions will be shared after completion of the study. Please indicate your desire to receive this information by providing your name and address at the end of the online survey. Your identifiers will not be linked to the survey questionnaire. Those conducting the survey anticipate that it will be completed by June, 2009.	Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org. ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters. New Postings: Click here to view full list of new postings
ClotCare Home \| New Postings \| Patient Postings \| Clinician Postings \| Join Our Email List \| Useful Web Links CE Opportunities \| Training Programs \| DVT & PE Stories \| Editorial Board \| Financial Support About ClotCare \| DVT Coalition \| Donate to ClotCare \| Contact Us
Key topics discussed on ClotCare include: Blood Clots \| Deep Vein Thrombosis (DVT) \| Pulmonary Embolism (PE) \| Atrial Fibrillation (A. Fib or AF) \| Heart Attack \| Stroke \| Transient Ischemic Attack (TIA) \| Mini Stroke \| Bleeding Complications \| Vascular Surgery \| Surgical Blood Clot Removal \| Warfarin \| Coumadin \| Lovenox \| Low Molecular Weight Heparin (LMWH) \| Heparin \| Anticoagulants \| Plavix \| Aspirin \| Antiplatelets \| Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved. Terms, Conditions, & Privacy \| Image Copyright Information 19260 Stone Oak Parkway, Suite 101 \| San Antonio, TX 78258 \| 210-860-0487 Send comments to webmaster@clotcare.org. Tuesday, December 3, 2024